Accelr8 2012 Revenues Narrow Sharply | GenomeWeb

NEW YORK (GenomeWeb News) – Accelr8 Technology on Friday reported a sharp drop in revenues for its Fiscal Year 2012.

In a document filed with the US Securities and Exchange Commission, the company said that revenues dropped to $235,910 for its Fiscal Year 2012 ended July 31, 2012, compared to $1.1 million in Fiscal Year 2011.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CBC Marketplace commissions DNA testing of chicken sandwiches at Subway and other fast-food chains.

In a speech to Congress, President Donald Trump called the drug approval process at FDA "slow and burdensome."

In Genome Research this week: algorithm to tease out strains from metagenomic sequences, drug resistance mechanisms in cancer cells, and more.

Variants in the IFITM3 gene affect inflammatory response to infection, UPI reports.